1. At a Glance
₹124 ka share. ₹122 crore ka market cap. Quarterly revenue of ₹0.12 crore. And yet, Cura Technologies Ltd is back in investor conversations like that one cousin who failed UPSC five times but still updates LinkedIn with “Entrepreneur | Visionary | Hustler.”
This is a company that literally went through NCLT, CIRP, capital annihilation, promoter reset, and equity rebirth, and is now trying to whisper “IT services” again in a market where even mid-tier software companies are shouting AI, Cloud, and GenAI from rooftop billboards.
The stock is down 44% in the last three months, ROCE is -10.7%, ROE is -16.7%, debt is ₹4.32 crore, book value is ₹7.93, and the stock trades at a proud 15.6× book value — which is impressive for a company that only recently remembered how to invoice customers.
Latest quarterly results show ₹12 lakh revenue and ₹1 lakh loss, which technically qualifies as “operations,” emotionally qualifies as “beta testing,” and financially qualifies as “please be patient.”
Is this a phoenix story or a corporate reboot stuck on loading screen? Let’s audit this resurrection properly.
2. Introduction – From Tech Dreams to Tribunal Reality
Cura Technologies was incorporated in 1991, when software meant floppy disks, consulting meant PowerPoint printouts, and pharma diversification sounded like a brilliant idea after one too many boardroom coffees.
Over the years, Cura tried many avatars — IT services, consulting, pharma, manpower placement — basically the Indian corporate version of “Jack of all trades, master of Excel sheets.”
Then came the dark phase. No working capital. No meaningful revenue. Continuous losses. Eventually, creditors knocked, patience evaporated, and in September 2023, the company entered Corporate Insolvency Resolution Process (CIRP) under NCLT Hyderabad.
What followed was not a gentle restructuring. It was a financial demolition and rebuild:
- 100% of promoter equity wiped out
- 95% of public equity written down
- Fresh shares issued to resolution applicant
- New management
- New board
- New MOA
- Same old BSE ticker
By FY24–FY25, Cura technically survived. By FY26, it started reporting small revenues again, enough to convince the exchange that the company is alive and not a PDF error.
But revival stories are judged not by intentions, but by invoices. And Cura’s invoices are still the size of Ola cab receipts.
So the real question: Is this a turnaround in progress or just compliance-level activity to keep the lights on?
3. Business Model – WTF Do They Even Do?
Officially, Cura Technologies now focuses on:
- IT services
- Manpower recruitment
- Healthcare services
- Inorganic growth via acquisitions
Unofficially, it is still in “finding product-market fit after insolvency” mode.
The company does not currently disclose any large clients, enterprise contracts, recurring SaaS revenues, or marquee staffing mandates. Whatever revenue is coming in appears to be project-based, small-ticket, and inconsistent.
Manpower placement is a low-margin, high-competition business where scale matters. IT services without niche expertise is basically a red ocean where even sharks are starving.
Healthcare is
